Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, November 2000, p. 3210-3212, Vol. 44, No. 11
Department of Biochemistry and Biophysics and
Center for Advanced Biomolecular Research, Texas A&M University,
College Station, Texas 77843-2128
Received 27 March 2000/Returned for modification 1 July
2000/Accepted 12 August 2000
Many laboratory strains of Escherichia coli are
resistant to methotrexate (MTX), a folate analogue that binds
dihydrofolate reductase (DHFR). Mutations that inactivate either
tolC or acrA confer MTX sensitivity.
Further, overexpression of a fusion protein with DHFR activity reverses
this sensitivity by titrating out intracellular MTX. These results
suggest that MTX accumulates in cells where mutations in
acrA or tolC have inactivated the TolC-dependent AcrAB multidrug resistance efflux pump.
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Resistance to Methotrexate Due to
AcrAB-Dependent Export from Escherichia coli

*
Corresponding author. Mailing address: Department of
Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843-2128. Phone: (979) 862-4054. Fax: (979) 845-4946. E-mail: jimhu{at}tamu.edu.
Present address: Columbia University, Department of Chemistry, New
York, NY 10027.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |